Lupin gets European Commission nod for myotonia treatment drug
The approval makes NaMuscla (mexiletine) the first treatment to be licensed throughout the EU for the symptomatic treatment of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
EyeC to present print inspection solutions for pharma packaging at Pharmapack 2019
The products will be exhibited at booth C2
Merck loses bid to revive $200 million Gilead verdict at US high court
Merck had urged the Supreme Court to place limits on the doctrine of 'unclean hands' that can prevent plaintiffs from winning…
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal
The two companies said the new arrangement would give Sanofi increased flexibility to advance its early-stage immuno-oncology…
HC sets aside Centre’s ban on anti-inflammatory medicine ‘Ace Proxyvon’
This is the first petition, filed against the Health Ministry's notification, to be decided by the court
Antares Vision and ALP.I in agreement
The general meeting to approve the business combination will be held in February 2019
Lupin gets US FDA nod for generic schizophrenia drug
The drug is a generic version os Sunovion Pharmaceuticals' Latuda tablets
Eris Lifesciences collaborates with Medtronic
The two companies will utilise their respective strengths in helping patients monitor their diabetes better
A collaborative…
PharmaHopers launches derma franchise category for B2B businesses
PharmaHopers, based on the market research and study, claims to provide good business opportunities in the dermatology sector by…
Overview of API market
Saurabh Gurnurkar, Executive Director, UQUIFA, talks about the developments in pharma / API industry, what went wrong and what was…